Download Drug Safety In Developing Countries Book PDF

Download full Drug Safety In Developing Countries books PDF, EPUB, Tuebl, Textbook, Mobi or read online Drug Safety In Developing Countries anytime and anywhere on any device. Get free access to the library by create an account, fast download and ads free. We cannot guarantee that every book is in the library.

Drug Safety in Developing Countries

Drug Safety in Developing Countries
  • Author : Yaser Mohammed Al-Worafi
  • Publisher :Unknown
  • Release Date :2020-06-03
  • Total pages :686
  • ISBN : 9780128204122
GET BOOK HERE

Summary : Drug Safety in Developing Countries: Achievements and Challenges provides comprehensive information on drug safety issues in developing countries. Drug safety practice in developing countries varies substantially from country to country. This can lead to a rise in adverse reactions and a lack of reporting can exasperate the situation and lead to negative medical outcomes. This book documents the history and development of drug safety systems, pharmacovigilance centers and activities in developing countries, describing their current situation and achievements of drug safety practice. Further, using extensive case studies, the book addresses the challenges of drug safety in developing countries. Provides a single resource for educators, professionals, researchers, policymakers, organizations and other readers with comprehensive information and a guide on drug safety related issues Describes current achievements of drug safety practice in developing countries Addresses the challenges of drug safety in developing countries Provides recommendations, including practical ways to implement strategies and overcome challenges surrounding drug safety

Drug Safety in Developing Countries

Drug Safety in Developing Countries
  • Author : Yaser Mohammed Al-Worafi
  • Publisher :Unknown
  • Release Date :2020-06-03
  • Total pages :686
  • ISBN : 9780128204122
GET BOOK HERE

Summary : Drug Safety in Developing Countries: Achievements and Challenges provides comprehensive information on drug safety issues in developing countries. Drug safety practice in developing countries varies substantially from country to country. This can lead to a rise in adverse reactions and a lack of reporting can exasperate the situation and lead to negative medical outcomes. This book documents the history and development of drug safety systems, pharmacovigilance centers and activities in developing countries, describing their current situation and achievements of drug safety practice. Further, using extensive case studies, the book addresses the challenges of drug safety in developing countries. Provides a single resource for educators, professionals, researchers, policymakers, organizations and other readers with comprehensive information and a guide on drug safety related issues Describes current achievements of drug safety practice in developing countries Addresses the challenges of drug safety in developing countries Provides recommendations, including practical ways to implement strategies and overcome challenges surrounding drug safety

Drug Safety Amendments of 1976

Drug Safety Amendments of 1976
  • Author : United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Health and the Environment
  • Publisher :Unknown
  • Release Date :1976
  • Total pages :545
  • ISBN : UOM:39015081219258
GET BOOK HERE

Summary :

Promoting Safety of Medicines for Children

Promoting Safety of Medicines for Children
  • Author : World Health Organization
  • Publisher :Unknown
  • Release Date :2007
  • Total pages :59
  • ISBN : 9789241563437
GET BOOK HERE

Summary : Monitoring the safety of medicine use in children is of paramount importance since, during the clinical development of medicines, only limited data on this aspect are generated through clinical trials. Use of medicines outside the specifications described in the license (e.g. in terms of formulation, indications, contraindications or age) constitutes off-label and off-license use and these are a major area of concern. These guidelines are intended to improve awareness of medicine safety issues among everyone who has an interest in the safety of medicines in children and to provide guidance on effective systems for monitoring medicine safety in the pediatric populations. This book will be of interest to all health care professionals, medicine regulatory authorities, pharmacovigilance centers, academia, the pharmaceutical industry and policy-makers. Systems for monitoring medicine safety are described in Annex 1. Pharmacovigilance methods and some examples of recent information on adverse reactions to marketed medicines are discussed in Annex 2.--Publisher's description.

Drug Safety and Pricing

Drug Safety and Pricing
  • Author : United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions
  • Publisher :Unknown
  • Release Date :2000
  • Total pages :117
  • ISBN : PSU:000047032026
GET BOOK HERE

Summary :

Pharmacy Practice in Developing Countries

Pharmacy Practice in Developing Countries
  • Author : Ahmed Fathelrahman,Mohamed Ibrahim,Albert Wertheimer
  • Publisher :Unknown
  • Release Date :2016-02-13
  • Total pages :516
  • ISBN : 9780128017111
GET BOOK HERE

Summary : Pharmacy Practice in Developing Countries: Achievements and Challenges offers a detailed review of the history and development of pharmacy practice in developing countries across Africa, Asia, and South America. Pharmacy practice varies substantially from country to country due to variations in needs and expectations, culture, challenges, policy, regulations, available resources, and other factors. This book focuses on each country’s strengths and achievements, as well as areas of weakness, barriers to improvement and challenges. It sets out to establish a baseline for best practices, taking all of these factors into account and offering solutions and opportunities for the future. This book is a valuable resource for academics, researchers, practicing pharmacists, policy makers, and students involved in pharmacy practice worldwide as it provides lessons learned on a global scale and seeks to advance the pharmacy profession. Uses the latest research and statistics to document the history and development of pharmacy practice in developing countries Describes current practice across various pharmacy sectors to supply a valuable comparative analysis across countries in Africa, Asia, Europe, and South America Highlights areas of achievement, strengths, uniqueness, and future opportunities to provide a basis for learning and improvement Establishes a baseline for best practices and solutions

Food and Drug Safety, Public Health, and the Environment in China

Food and Drug Safety, Public Health, and the Environment in China
  • Author : United States. Congressional-Executive Commission on China
  • Publisher :Unknown
  • Release Date :2013
  • Total pages :59
  • ISBN : UCAL:B5627540
GET BOOK HERE

Summary :

Monitoring for Drug Safety

Monitoring for Drug Safety
  • Author : William Howard Wallace Inman
  • Publisher :Unknown
  • Release Date :1980
  • Total pages :673
  • ISBN : UOM:39015003225706
GET BOOK HERE

Summary :

Pharmaceutical Medicine and Translational Clinical Research

Pharmaceutical Medicine and Translational Clinical Research
  • Author : Divya Vohora,Gursharan Singh
  • Publisher :Unknown
  • Release Date :2017-11-14
  • Total pages :526
  • ISBN : 9780128020982
GET BOOK HERE

Summary : Pharmaceutical Medicine and Translational Clinical Research covers clinical testing of medicines and the translation of pharmaceutical drug research into new medicines, also focusing on the need to understand the safety profile of medicine and the benefit-risk balance. Pharmacoeconomics and the social impact of healthcare on patients and public health are also featured. It is written in a clear and straightforward manner to enable rapid review and assimilation of complex information and contains reader-friendly features. As a greater understanding of these aspects is critical for students in the areas of pharmaceutical medicine, clinical research, pharmacology and pharmacy, as well as professionals working in the pharmaceutical industry, this book is an ideal resource. Includes detailed coverage of current trends and key topics in pharmaceutical medicine, including biosimilars, biobetters, super generics, and Provides a comprehensive look at current and important aspects of the science and regulation of drug and biologics discovery

Industrial Guide to Chemical and Drug Safety

Industrial Guide to Chemical and Drug Safety
  • Author : T. S. S. Dikshith,Prakash V. Diwan
  • Publisher :Unknown
  • Release Date :2003-05-27
  • Total pages :629
  • ISBN : 0471458775
GET BOOK HERE

Summary : Exposure to a wide variety of chemicals and drugs has become common in industrial, laboratory, and even household environments. Fortunately, global understanding and consequently global safety standards regarding the management of toxic and hazardous substances are fast approaching uniformity. The methods of handling, use, transportation, storage, and disposal in particular are moving toward standardization. As these protocols involving chemicals and drugs continue to cross international borders, students and professionals need a reliable resource to ensure they observe appropriate safety standards. The Industrial Guide to Chemical and Drug Safety covers not only current standards, but also a wealth of information on toxins to help regulatory bodies develop new protocols. Written in an accessible narrative style, the Guide covers chemicals by key classes such as solvents, pesticides, and metals, and also by key industries such as drugs, food additives, plastics, cosmetics, detergents, and soaps. The book explains the beneficial and harmful aspects of a broad range of materials to which students, trainees, skilled workers, managers, and personnel associated with regulatory agencies are exposed, with the purpose of helping them avoid the illnesses associated with the misuse of chemicals and drugs. Chapters include: -Heavy Metals -Pesticides -Industrial Solvents -Industrial Gases and Fumes -Drugs -Target Organ Toxicity -Disposal of Hazardous Chemicals -Guidance to Students and Workers -Good Laboratory Practice

Reducing Urban Violence in the Global South

Reducing Urban Violence in the Global South
  • Author : Jennifer Erin Salahub,Markus Gottsbacher,John de Boer,Mayssam D. Zaaroura
  • Publisher :Unknown
  • Release Date :2019-05-14
  • Total pages :246
  • ISBN : 9781351254625
GET BOOK HERE

Summary : Reducing Urban Violence in the Global South seeks to identify the drivers of urban violence in the cities of the Global South and how they relate to and interact with poverty and inequalities. Drawing on the findings of an ambitious 5-year, 15-project research programme supported by Canada’s International Development Research Centre and the UK’s Department for International Development, the book explores what works, and what doesn't, to prevent and reduce violence in urban centres. Cities in developing countries are often seen as key drivers of economic growth, but they are often also the sites of extreme violence, poverty, and inequality. The research in this book was developed and conducted by researchers from the Global South, who work and live in the countries studied; it challenges many of the assumptions from the Global North about how poverty, violence, and inequalities interact in urban spaces. In so doing, the book demonstrates that accepted understandings of the causes of and solutions to urban violence developed in the Global North should not be imported into the Global South without careful consideration of local dynamics and contexts. Reducing Urban Violence in the Global South concludes by considering the broader implications for policy and practice, offering recommendations for improving interventions to make cities safer and more inclusive. The fresh perspectives and insights offered by this book will be useful to scholars and students of development and urban violence, as well as to practitioners and policymakers working on urban violence reduction programmes.

Countering the Problem of Falsified and Substandard Drugs

Countering the Problem of Falsified and Substandard Drugs
  • Author : Institute of Medicine,Board on Global Health,Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products
  • Publisher :Unknown
  • Release Date :2013-06-20
  • Total pages :376
  • ISBN : 9780309269391
GET BOOK HERE

Summary : The adulteration and fraudulent manufacture of medicines is an old problem, vastly aggravated by modern manufacturing and trade. In the last decade, impotent antimicrobial drugs have compromised the treatment of many deadly diseases in poor countries. More recently, negligent production at a Massachusetts compounding pharmacy sickened hundreds of Americans. While the national drugs regulatory authority (hereafter, the regulatory authority) is responsible for the safety of a country's drug supply, no single country can entirely guarantee this today. The once common use of the term counterfeit to describe any drug that is not what it claims to be is at the heart of the argument. In a narrow, legal sense a counterfeit drug is one that infringes on a registered trademark. The lay meaning is much broader, including any drug made with intentional deceit. Some generic drug companies and civil society groups object to calling bad medicines counterfeit, seeing it as the deliberate conflation of public health and intellectual property concerns. Countering the Problem of Falsified and Substandard Drugs accepts the narrow meaning of counterfeit, and, because the nuances of trademark infringement must be dealt with by courts, case by case, the report does not discuss the problem of counterfeit medicines.

Drug Surveillance

Drug Surveillance
  • Author : Zbigniew Bańkowski,John F. Dunne
  • Publisher :Unknown
  • Release Date :1993-12-31
  • Total pages :198
  • ISBN : UCAL:B4767456
GET BOOK HERE

Summary : Records the proceedings of an international conference convened to consider mechanisms for improving international cooperation in the surveillance of drug safety and the reporting of adverse reactions. Attended by close to 200 representatives of regulatory authorities and the pharmaceutical industry as well as clinical pharmacologists, the conference aimed to identify the strengths and weaknesses of existing mechanisms for international cooperation and to propose improvements for the future.

Innocent Bystanders

Innocent Bystanders
  • Author : Philip Keefer,Norman Loayza
  • Publisher :Unknown
  • Release Date :2010-03-24
  • Total pages :388
  • ISBN : 0821380354
GET BOOK HERE

Summary : This book presents evidence that drug policies impose high costs on poor transit and producer countries. It argues that, in the face of great uncertainty about the benefits of alternative drug policies, those with lower social costs should receive greater emphasis.

International Regulatory Harmonization Amid Globalization of Drug Development

International Regulatory Harmonization Amid Globalization of Drug Development
  • Author : Institute of Medicine,Board on Health Sciences Policy,Forum on Drug Discovery, Development, and Translation
  • Publisher :Unknown
  • Release Date :2013-11-24
  • Total pages :128
  • ISBN : 9780309284790
GET BOOK HERE

Summary : The past several decades have been a time of rapid globalization in the development, manufacture, marketing, and distribution of medical products and technologies. Increasingly, research on the safety and effectiveness of new drugs is being conducted in countries with little experience in regulation of medical product development. Demand has been increasing for globally harmonized, science-based standards for the development and evaluation of the safety, quality, and efficacy of medical products. Consistency of such standards could improve the efficiency and clarity of the drug development and evaluation process and, ultimately, promote and enhance product quality and the public health. To explore the need and prospects for greater international regulatory harmonization for drug development, the IOM Forum on Drug Discovery, Development, and Translation hosted a workshop on February 13-14, 2013. Discussions at the workshop helped identify principles, potential approaches, and strategies to advance the development or evolution of more harmonized regulatory standards. This document summarizes the workshop.

Drugs Policy in Developing Countries

Drugs Policy in Developing Countries
  • Author : Najmi Kanji,Anita Hardon,Gill Walt
  • Publisher :Unknown
  • Release Date :1992-09
  • Total pages :136
  • ISBN : STANFORD:36105022856756
GET BOOK HERE

Summary : This policy-relevant study grew out of an evaluation conducted by its authors - all scholars at the London School of Hygiene & Tropical Medicine and the Royal Tropical Institute, Amsterdam - of the World Health Organization's Action Programme on Essential Drugs. Their review, involving 13 country studies and WHO's five regional offices, looks at how the idea of a rational drug policy in developing countries came about, evaluates the achievements in specific countries, and discusses some of the issues that remain to be resolved - particularly issues around AIDs, contraception and cost recovery. It should prove useful to policy makers and academics, teachers and students, managers and professionals, as well as international agencies in the health field.

Science, Medicine, and Animals

Science, Medicine, and Animals
  • Author : National Research Council,Division on Earth and Life Studies,Institute for Laboratory Animal Research
  • Publisher :Unknown
  • Release Date :2006-01-19
  • Total pages :23
  • ISBN : 0309181992
GET BOOK HERE

Summary : Science, Medicine, and Animals explains the role that animals play in biomedical research and the ways in which scientists, governments, and citizens have tried to balance the experimental use of animals with a concern for all living creatures. An accompanying Teacher’s Guide is available to help teachers of middle and high school students use Science, Medicine, and Animals in the classroom. As students examine the issues in Science, Medicine, and Animals, they will gain a greater understanding of the goals of biomedical research and the real-world practice of the scientific method in general. Science, Medicine, and Animals and the Teacher’s Guide were written by the Institute for Laboratory Animal Research and published by the National Research Council of the National Academies. The report was reviewed by a committee made up of experts and scholars with diverse perspectives, including members of the U.S. Department of Agriculture, National Institutes of Health, the Humane Society of the United States, and the American Society for the Prevention of Cruelty to Animals. The Teacher’s Guide was reviewed by members of the National Academies’ Teacher Associates Network. Science, Medicine, and Animals is recommended by the National Science Teacher’s Association NSTA Recommends.

When Experiments Travel

When Experiments Travel
  • Author : Adriana Petryna
  • Publisher :Unknown
  • Release Date :2009-04-27
  • Total pages :272
  • ISBN : 1400830826
GET BOOK HERE

Summary : The phenomenal growth of global pharmaceutical sales and the quest for innovation are driving an unprecedented search for human test subjects, particularly in middle- and low-income countries. Our hope for medical progress increasingly depends on the willingness of the world's poor to participate in clinical drug trials. While these experiments often provide those in need with vital and previously unattainable medical resources, the outsourcing and offshoring of trials also create new problems. In this groundbreaking book, anthropologist Adriana Petryna takes us deep into the clinical trials industry as it brings together players separated by vast economic and cultural differences. Moving between corporate and scientific offices in the United States and research and public health sites in Poland and Brazil, When Experiments Travel documents the complex ways that commercial medical science, with all its benefits and risks, is being integrated into local health systems and emerging drug markets. Providing a unique perspective on globalized clinical trials, When Experiments Travel raises central questions: Are such trials exploitative or are they social goods? How are experiments controlled and how is drug safety ensured? And do these experiments help or harm public health in the countries where they are conducted? Empirically rich and theoretically innovative, the book shows that neither the language of coercion nor that of rational choice fully captures the range of situations and value systems at work in medical experiments today. When Experiments Travel challenges conventional understandings of the ethics and politics of transnational science and changes the way we think about global medicine and the new infrastructures of our lives.

Increasing Drug Access to Developing Countries

Increasing Drug Access to Developing Countries
  • Author : Megan DeYoung
  • Publisher :Unknown
  • Release Date :2002
  • Total pages :101
  • ISBN : UOM:39015052696070
GET BOOK HERE

Summary :

Ensuring Safe Foods and Medical Products Through Stronger Regulatory Systems Abroad

Ensuring Safe Foods and Medical Products Through Stronger Regulatory Systems Abroad
  • Author : Institute of Medicine,Board on Health Sciences Policy,Board on Global Health,Committee on Strengthening Core Elements of Food and Drug Regulatory Systems in Developing Countries
  • Publisher :Unknown
  • Release Date :2012-09-03
  • Total pages :366
  • ISBN : 9780309224086
GET BOOK HERE

Summary : A very high portion of the seafood we eat comes from abroad, mainly from China and Southeast Asia, and most of the active ingredients in medicines we take originate in other countries. Many low- and middle-income countries have lower labor costs and fewer and less stringent environmental regulations than the United States, making them attractive places to produce food and chemical ingredients for export. Safe Foods and Medical Products Through Stronger Regulatory Systems Abroad explains that the diversity and scale of imports makes it impractical for U.S. Food and Drug Administration (FDA) border inspections to be sufficient to ensure product purity and safety, and incidents such as American deaths due to adulterated heparin imported from China propelled the problem into public awareness. The Institute of Medicine Committee on Strengthening Core Elements of Regulatory Systems in Developing Countries took up the vital task of helping the FDA to cope with the reality that so much of the food, drugs, biologics, and medical products consumed in the United States originate in countries with less-robust regulatory systems. Ensuring Safe Foods and Medical Products Through Stronger Regulatory Systems Abroad describes the ways the United States can help strengthen regulatory systems in low and middle income countries and promote cross-border partnerships - including government, industry, and academia - to foster regulatory science and build a core of regulatory professionals. This report also emphasizes an array of practical approaches to ensure sound regulatory practices in today's interconnected world.

The Pharmaceutical Corporate Presence in Developing Countries

The Pharmaceutical Corporate Presence in Developing Countries
  • Author : Lee A. Tavis
  • Publisher :Unknown
  • Release Date :1993
  • Total pages :366
  • ISBN : UOM:39015032154224
GET BOOK HERE

Summary : The book begins by analyzing the overall issue of multinational pharmaceutical corporate involvement in Third World locations. The contributors discuss the broad issue of conflict and collaboration between multinational corporations and activists, the role of pharmaceuticals in Third World health care, and the role of multinational corporations in that process.